Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 175

    1.

    Contribution of elevated free fatty acid levels to the lack of glucose effectiveness in type 2 diabetes.

    Hawkins M, Tonelli J, Kishore P, Stein D, Ragucci E, Gitig A, Reddy K.

    Diabetes. 2003 Nov;52(11):2748-58.PMID: 14578293 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Time-dependent effects of free fatty acids on glucose effectiveness in type 2 diabetes.

    Kishore P, Tonelli J, Koppaka S, Fratila C, Bose A, Lee DE, Reddy K, Hawkins M.

    Diabetes. 2006 Jun;55(6):1761-8.PMID: 16731840 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Glycemic control determines hepatic and peripheral glucose effectiveness in type 2 diabetic subjects.

    Hawkins M, Gabriely I, Wozniak R, Reddy K, Rossetti L, Shamoon H.

    Diabetes. 2002 Jul;51(7):2179-89.PMID: 12086948 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    A sustained increase in plasma free fatty acids impairs insulin secretion in nondiabetic subjects genetically predisposed to develop type 2 diabetes.

    Kashyap S, Belfort R, Gastaldelli A, Pratipanawatr T, Berria R, Pratipanawatr W, Bajaj M, Mandarino L, DeFronzo R, Cusi K.

    Diabetes. 2003 Oct;52(10):2461-74.PMID: 14514628 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Effects of fatty acids and ketone bodies on basal insulin secretion in type 2 diabetes.

    Boden G, Chen X.

    Diabetes. 1999 Mar;48(3):577-83.PMID: 10078559 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    High plasma free fatty acids decrease splanchnic glucose uptake in patients with non-insulin-dependent diabetes mellitus.

    Tomita T, Yamasaki Y, Kubota M, Tohdo R, Katsura M, Ikeda M, Nakahara I, Shiba Y, Matsuhisa M, Hori M.

    Endocr J. 1998 Apr;45(2):165-73.PMID: 9700469 [PubMed - indexed for MEDLINE]Related articles

    7.

    Fructose improves the ability of hyperglycemia per se to regulate glucose production in type 2 diabetes.

    Hawkins M, Gabriely I, Wozniak R, Vilcu C, Shamoon H, Rossetti L.

    Diabetes. 2002 Mar;51(3):606-14.PMID: 11872657 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Effect of fatty acids on glucose production and utilization in man.

    Ferrannini E, Barrett EJ, Bevilacqua S, DeFronzo RA.

    J Clin Invest. 1983 Nov;72(5):1737-47.PMID: 6138367 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Effects of free fatty acids on gluconeogenesis and autoregulation of glucose production in type 2 diabetes.

    Boden G, Chen X, Capulong E, Mozzoli M.

    Diabetes. 2001 Apr;50(4):810-6.PMID: 11289046 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Impaired basal glucose effectiveness in NIDDM: contribution of defects in glucose disappearance and production, measured using an optimized minimal model independent protocol.

    Basu A, Caumo A, Bettini F, Gelisio A, Alzaid A, Cobelli C, Rizza RA.

    Diabetes. 1997 Mar;46(3):421-32.PMID: 9032098 [PubMed - indexed for MEDLINE]Related articles

    12.

    Discordant effects of a chronic physiological increase in plasma FFA on insulin signaling in healthy subjects with or without a family history of type 2 diabetes.

    Kashyap SR, Belfort R, Berria R, Suraamornkul S, Pratipranawatr T, Finlayson J, Barrentine A, Bajaj M, Mandarino L, DeFronzo R, Cusi K.

    Am J Physiol Endocrinol Metab. 2004 Sep;287(3):E537-46. Epub 2004 May 4.PMID: 15126243 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Effect of antecedent hypoglycemia on counterregulatory responses to subsequent euglycemic exercise in type 1 diabetes.

    Galassetti P, Tate D, Neill RA, Morrey S, Wasserman DH, Davis SN.

    Diabetes. 2003 Jul;52(7):1761-9.PMID: 12829644 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Effect of pioglitazone on circulating adipocytokine levels and insulin sensitivity in type 2 diabetic patients.

    Miyazaki Y, Mahankali A, Wajcberg E, Bajaj M, Mandarino LJ, DeFronzo RA.

    J Clin Endocrinol Metab. 2004 Sep;89(9):4312-9.PMID: 15356026 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    The regulation of glucose effectiveness: how glucose modulates its own production.

    Tonelli J, Kishore P, Lee DE, Hawkins M.

    Curr Opin Clin Nutr Metab Care. 2005 Jul;8(4):450-6. Review.PMID: 15930973 [PubMed - indexed for MEDLINE]Related articles

    16.

    Effects of free fatty acids on glucose uptake and utilization in healthy women.

    Homko CJ, Cheung P, Boden G.

    Diabetes. 2003 Feb;52(2):487-91.PMID: 12540625 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Prolonged elevation of plasma free fatty acids impairs pancreatic beta-cell function in obese nondiabetic humans but not in individuals with type 2 diabetes.

    Carpentier A, Mittelman SD, Bergman RN, Giacca A, Lewis GF.

    Diabetes. 2000 Mar;49(3):399-408.PMID: 10868961 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Effect of overnight restoration of euglycemia on glucose effectiveness in type 2 diabetes mellitus.

    Basu R, Basu A, Nielsen M, Shah P, Rizza RA.

    J Clin Endocrinol Metab. 1999 Jul;84(7):2314-9.PMID: 10404795 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Inhibiting gluconeogenesis prevents fatty acid-induced increases in endogenous glucose production.

    Kehlenbrink S, Tonelli J, Koppaka S, Chandramouli V, Hawkins M, Kishore P.

    Am J Physiol Endocrinol Metab. 2009 Jul;297(1):E165-73. Epub 2009 May 5.PMID: 19417129 [PubMed - indexed for MEDLINE]Related articles

    20.

    Lowering plasma free fatty acid levels improves insulin action in conscious pregnant rabbits.

    Gilbert M, Basile S, Baudelin A, Pere MC.

    Am J Physiol. 1993 Apr;264(4 Pt 1):E576-82.PMID: 8476036 [PubMed - indexed for MEDLINE]Related articles